We determined the dengue virus (DENV) serotypes and genotypes in archived serum samples that were collected during the 2014–2016 and 2021 dengue outbreaks in Dire Dawa City and the Somali region in Ethiopia. DENV serotype 1 (DENV-1) was predominant followed by DENV serotype 2 (DENV-2). Thirteen of the DENV-1 strains were assigned to Genotype-I, while the remaining two were found to be Genotype-III. All three DENV-2 strains were assigned the Cosmopolitan Genotype. The DENV strains responsible for the outbreaks are genetically closely related to the DENV strains that circulated in neighboring and Asian countries. The findings also showed continued local transmission of a monophyletic lineage and a co-circulation of DENV-1 and DENV-2 during the outbreaks. There is a need to strengthen DENV genomic surveillance capacity for the early detection of circulating serotypes, and prevent devastating consequences of future outbreaks due to the co-circulation of different serotypes.
Background: The COVID-19 pandemic highlighted SARS-CoV-2 variants with increased transmissibility and immune evasion. In Ethiopia, where cases surged, the understanding of the virus’s dynamics was limited. This study analyzed SARS-CoV-2 variants during the fifth wave, crucial for guiding vaccines, therapeutics, diagnostics, and understanding disease severity. Method: From June to August 2022, 150 SARS-CoV-2-positive samples were randomly selected from the Ethiopian Public Health Institute repository. Sixty-three high-quality genome sequences were analyzed. Results: Of the 63 sequences, 70% were from males and 30% from females, with a median age of 34. Omicron dominated (97%, 61/63), primarily clade 22A (64%, 40/63), followed by 22B (18%, 11/63) and 21K (14%, 9/63). Delta accounted for 3.2% (2/63). Omicron was identified in all (25) vaccinated study participants. Ethiopian sequences showed limited evolutionary divergence and lower genetic diversity compared to global sequences. Conclusion: Omicron was the predominant variant during Ethiopia’s fifth wave, indicating recent community transmission. Despite minor genetic diversity differences, ongoing surveillance remains critical for tracking variants and informing public health interventions.
Background: The Delta variant of SARS-CoV-2 virus, one of the alarming variants of concern (VOC) with a distinct mutation characteristic, was immensely detrimental and a significant cause of the prolonged pandemic waves. This study aimed to analyze the genetic characteristics of the predominant Delta variant in acute febrile illness (AFI) patients in Ethiopia. Method: Nasopharyngeal swab samples were collected from AFI patients in four hospitals from February 2021 to June 2022 and tested for SARS-CoV-2 by using RT-qPCR. Of 101 positive samples, 48 stored specimens were re-tested, and 26 with sufficient RNA quality (Ct < 30) were sequenced using whole-genome sequencing to identify variants of concern, specific virus lineages and mutation features. Result: Delta variants (21J clade) were found predominant among all the sequenced SARS-CoV-2 isolate (80.8%, 21/26). AY.120 (46.2%) and B.1.617.2 (26.9%) were the predominant sub-lineages of the Delta variant. Omicron (21k, Pango BA.1.1/BA.1.17/BA.1) and Alpha (20I, Pango B.1.1.7) variants accounted for 11.5% and 7.7% of the total sequenced samples. Phylogenetic analysis showed evidence of local transmission and possible multiple introductions of SARS-CoV-2 VOCs in Ethiopia. The number of mutations increases dramatically from Alpha (~35 avg) to Delta (~42 avg) to Omicron (~56 avg). The Delta variant revealed a spike mutation on L452R and T478K and P681R, and was characterized by the double deletion E156-F157- in Spike protein. Conclusions: The findings are indicative of a gradual change in the genetic coding of the virus underscoring the importance of ongoing genomic surveillance to track the evolution and spread of SARS-CoV-2 and other emerging virus.
Background: RT-qPCR is the gold standard for diagnosing COVID-19, the testing process requires RNA extraction, which can be time-consuming, costly and infectious. This study aimed to compare the diagnostic performance of an extraction-free heating and dilution method (EFHD) with conventional extraction-based (EB) methods for detecting SARS-CoV-2. Method: A total of 300 specimens, (190 positive, 110 negative) were collected retrospectively from the National Virology Reference Laboratory repository of Ethiopian Public Health Institute (EPHI). The specimens were diluted in 1:2 with RNase-free water and heated at 72°C for 15 minutes. 10µL of the heated sample/ elutes were mixed with 20µL of the master mix and runned using an ABI 7500 Fast instrument (ThermoFisher Scientific). Performance characteristics were analyzed using R-Studio and STATA v17. Result: The EFHD revealed a sensitivity of 92% and a specificity of 100%. The accuracy of the new method was 85.8% (163/190). The new method reported 15 false negatives and 12 invalid results. The EFHD method exhibited strong agreement with the standard method, (with an agreement of 95%, and a kappa coefficient of 0.89). It performed well with high viral load samples (Ct < 20), but exhibited reduced sensitivity for lower viral loads (Ct > 35). The study confirmed a significant correlation (R² = 0.99, p = 0.001) between EFHD and extraction-based SARS CoV-2 detection methods. Conclusion: EFHD demonstrated good performance characteristics. Its tendency to produce false negatives in low viral load cases suggests room for improvement. This method could be the choice of testing in resource-limited areas specially for outbreak management and control.
Real-time quantitative polymerase chain reaction remains the gold standard for COVID-19 diagnosis, but RNA extraction is time-consuming, expensive, and associated with increased biosafety requirements. This study evaluated an extraction-free dilution and heating (EFDH) method as a simplified alternative to conventional extraction-based (EB) real-time quantitative polymerase chain reaction for severe acute respiratory syndrome coronavirus 2 detection. A total of 300 archived nasopharyngeal specimens, including 190 positives and 110 negatives, from the National Virology Reference Laboratory at the Ethiopian Public Health Institute, were analyzed. Samples were diluted 1:2 with RNase-free water, heated at 72°C for 15 min, and analyzed using an ABI 7500 Fast instrument. The EFDH method showed a sensitivity of 92%, a specificity of 100%, and an overall accuracy of 85.8%, producing 15 false-negative and 12 invalid results. Agreement with the EB method was high, with 95% concordance and a kappa coefficient of 0.89. Performance was strongest in samples with high viral loads (cycle threshold [Ct] < 20) and declined in those with low viral loads (Ct > 35). A significant correlation was observed between the two methods (R2 = 0.99, p=0.001). These findings indicate that the EFDH approach reliably detects moderate-to-high viral loads and may serve as a practical testing option in resource-limited settings, especially during outbreaks when rapid and simplified workflows are needed.